Protocolo basado en la evidencia para el diagnóstico y tratamiento del paciente adulto con depresión en el Hospital Universitario Nacional de Colombia

dc.contributor.advisorCalvo, José Manuel
dc.contributor.advisorCarlos Fernando, Grillo Ardila
dc.contributor.authorMorales Pinilla, Luisa Fernanda
dc.date.accessioned2022-03-01T23:33:01Z
dc.date.available2022-03-01T23:33:01Z
dc.date.issued2021
dc.descriptionilustraciones, tablasspa
dc.description.abstractLa atención oportuna y adecuada de las enfermedades más prevalentes, requiere entre otros aspectos, la implementación de estándares mínimos de atención en salud, que garanticen tanto a pacientes como a cuidadores, que se recibe y proporciona una atención segura, efectiva y eficiente. El presente documento, contiene las directrices metodológicas y las preguntas clínicas formuladas así como los lineamientos con una descripción breve de la evidencia que los soporta y que conforman el “PROTOCOLO BASADO EN LA EVIDENCIA PARA EL DIAGNÓSTICO Y TRATAMIENTO DEL PACIENTE ADULTO CON DEPRESIÓN EN EL HOSPITAL UNIVERSITARIO NACIONAL DE COLOMBIA. (Texto tomado de la fuente)spa
dc.description.abstractThe timely and adequate care of the most prevalent diseases requires, among other aspects, the implementation of minimum standards of health care, which guarantee both patients and caregivers that safe, effective and efficient care is received and provided. This document contains the methodological guidelines and the clinical questions formulated as well as the recommendations with a brief description of the evidence that supports them and that make up the "EVIDENCE-BASED PROTOCOL FOR THE DIAGNOSIS AND TREATMENT OF THE ADULT PATIENT WITH DEPRESSION IN THE COLOMBIA NATIONAL UNIVERSITY HOSPITAL”.eng
dc.description.degreelevelEspecialidades Médicasspa
dc.description.degreenameEspecialista en Psiquiatríaspa
dc.format.extent100 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.identifier.instnameUniversidad Nacional de Colombiaspa
dc.identifier.reponameRepositorio Institucional Universidad Nacional de Colombiaspa
dc.identifier.repourlhttps://repositorio.unal.edu.co/spa
dc.identifier.urihttps://repositorio.unal.edu.co/handle/unal/81106
dc.language.isospaspa
dc.publisherUniversidad Nacional de Colombiaspa
dc.publisher.branchUniversidad Nacional de Colombia - Sede Bogotáspa
dc.publisher.departmentDepartamento de Psiquiatríaspa
dc.publisher.facultyFacultad de Medicinaspa
dc.publisher.placeBogotá, Colombiaspa
dc.publisher.programBogotá - Medicina - Especialidad en Psiquiatríaspa
dc.relation.referencesMinisterio de Sanidad, Servicios Sociales e Igualdad. (2014). Guía de Práctica Clínica Sobre el Manejo de la Depresión en el Adulto. Galicia: Agencia de Evaluación de Tecnologías Sanitarias de Galicia, avalia-t. Conselleria de Sanidad, Ministerio de Sanidad, Servicios Sociales e Igualdad.spa
dc.relation.referencesNational Institute for Health & Clinical Excellence. (2019). DEPRESSION. The Nice Guideline On The Treatment And Management Of Depression In Adults. London: The British Psychological Society and The Royal College of Psychiatrists.spa
dc.relation.referencesGroup, T. G. (2004). The Grading of Recommendations Assessment, Development and Evaluation. Obtenido de GRADE: https://www.gradeworkinggroup.org/spa
dc.relation.referencesResearch, C. I. (2009). APPRAISAL OF GUIDELINES FOR RESEARCH & EVALUATION II. McMaster University, Hamilton, Ontario, Canada: AGREE Next Steps Consortium.spa
dc.relation.referencesColombiano, G. d. (2014). Guía Metodológica para la elaboración de Guías de Práctica Clínica con Evaluación Económica en el Sistema General de Seguridad Social en Salud Colombiano. Obtenido de https://www.iets.org.co/Archivos/62/Gu%C3%ADa%20Metodol%C3%B3gica%20El aboraci%C3%B3n%20de%20GPC%20con%20Evaluaci%C3%B3n%20Econ%C3%B3mi ca%20en%20el%20Sist%20Seguridad%20Social%20y%20SaludVersi%C3%B3n%20final%20completa.PDFspa
dc.relation.referencesPatricia B. Burns, R. J. (2011). The Levels of Evidence and their role in Evidence-Based Medicine. Plast Reconstr Surg, 305-311.spa
dc.relation.referencesVallejo-Ortega MT, S.-P. R.-A.-P.-S.-C. (2016). Manual Metodológico para la elaboración de protocolos clínicos en el Instituto Nacional de Cancerología. Bogotá: Instituto Nacional de Cancerología.spa
dc.relation.referencesJames Atkinson, Y. C.-S. (2007). Natural Ventilation for Infection Control in Health-Care Settings. Switzerland: WHO Publication/Guidelines.spa
dc.relation.referencesMoussavi, S. C. (2007). Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet, 370, 851-858.spa
dc.relation.referencesCassano, P. &. (2002). Depression and public health: an overview. . Journal of Psychosomatic Research, 53., 849-857.spa
dc.relation.referencesHeilbron, N., Compton, J., & Goldston, D. (2010, 41). The Problematic Label of Suicide Gesture: Alternatives for Clinical Research and Practice. Professional Psychology, Research and Practice, 221-227.spa
dc.relation.referencesShea, S. C. (2002). La entrevista psiquiátrica. El arte de comprender. . Madrid, España.: Ediciones Harcourtspa
dc.relation.referencesPim Cuijpers, A. T. (March 14, 2012). Preventing Depression. A Global Priority. Journal of the American Medical Association., Vol 307, No. 10.spa
dc.relation.referencesStockings EA, D. L. (2016). Preventing depression and anxiety in young people: a review of the joint efficacy of universal, selective and indicated prevention. Psychlogical Medicine, 46:11-26.spa
dc.relation.referencesBrugha, T. W. (2000). Pragmatic randomized trial of antenatal intervention to prevent post-natal depression by reducing psychosocial risk factors. Psychological Medicine, 30:1273-1281.spa
dc.relation.referencesVan Zoonen K, B. C. (2014). Preventing the onset of major depressive disorder: a metaanalytic review of psychological interventions. International Journal of Epidemiology., 43:318-329.spa
dc.relation.referencesWillemse GRWM, S. F. (2004). Minimal contact psychotherapy for sub-threshold depression in primary care: a randomised trial. Br J Psychiatry, 185:416-421.spa
dc.relation.referencesVan ’t Veer-Tazelaar PA, v. M. (2009). Stepped-care prevention of anxiety and depression in late life: a randomized controlled trial. . Archives of General Psychiatry, 66:297- 304spa
dc.relation.referencesFornés Vives, J. (2003). Enfermeria en Salud Mental. Como cuidar al cuidador.spa
dc.relation.referencesIan Colman, P. K. (2011, Nov 22). Predictors of long-term prognosis of depression. Canadian Medical Association Journal, 183(17): 1969-1976.spa
dc.relation.referencesChristoph Kraus, B. K. (2019). Prognosis and improved outcomes in major depression: a review. Translational Psychiatry, 9:127.spa
dc.relation.referencesStahl, S. M. (2014). Psicofarmacología Esencial de Stahl. Guía del Prescriptor. Quinta Edición. New York, USA: Aulamédica. Formación en saludspa
dc.relation.referencesOrganización Mundial de la Salud. (Marzo de 2020). Temas de Salud: Depresión. Obtenido de Sitio Web Mundial. Organización Mundial de la Salud.: https://www.who.int/topics/depression/es/spa
dc.relation.referencesOrganización Panamericana de la Salud. (30 de Marzo de 2017). "Depresión: hablemos", dice la OMS, mientras la depresión encabeza la lista de causas de enfermedad. Obtenido de OPS Web Site: https://www.paho.org/hq/index.php?option=com_content&view=article&id=1310 2:depression-lets-talk-says-who-as-depression-tops-list-of-causes-of-illhealth&Itemid=1926&lang=esspa
dc.relation.referencesOrganización Panamericana de la Salud, Oficina Sanitaria Panamericana. (1992). Clasificación Estadística Internacional de Enfermedades y Problemas Relacionados con la Salud. Décima Revisión. Washington, D.C. E.U.A: Oficina Regional de la Organización Mundial de la Saludspa
dc.relation.referencesMinisterio de Salud Y Protección Social de Colombia, Departamento Administrativo de Ciencia, Tecnología e Innovación. (2015). Encuesta Nacional de Salud Mental 2015 Tomo I. Bogotá, Colombia.spa
dc.relation.referencesMinisterio de Salud y Protección Social de Colombia, Colciencias. (2013). Guía de Práctica Clínica. Detección Temprana y Diagnóstico del Episodio Depresivo y Trastorno Depresivo Recurrente en Adultos. Bogotá, Colombiaspa
dc.relation.referencesAssociation, American Psychiatric. (2014). Manual Diagnóstico y Estadístico de los Trastornos Mentales. DSM-5. 5 Edición. Virginia, Estados Unidos.: Editorial Médica Panamericana.spa
dc.relation.referencesMinisterio de Salud y Protección Social de Colombia, SISPRO. (Marzo de 2020). Sistema Integrado de Información de la Protección Social, Observatorio Salud Mental. Obtenido de SISPRO Web Site: http://rssvr2.sispro.gov.co/ObsSaludMental/spa
dc.relation.referencesMinisterio de Salud y Protección Social, Pontificia Universidad Javeriana. . (2015). Depresión. Protocolo de Prevención y Actuacion en el Entorno Laboral. . Bogotá, Colombia.: Fundación Cultural Javeriana de Artes Gráficas - JAVEGRAFspa
dc.relation.referencesAgency for Healthcare Research and Quality U.S. Department of Health and Human Services. (2013). Screening ofr Suicide Risk in Primary Care: A Systematic Evidence Review for the U.S. Preventive Service Task Force. Portland: Agency for Healthcare Research and Quality U.S.spa
dc.relation.referencesWorld Health Organization. Regional Office for Europe. (2016). Preventing depression in the WHO European Region. Marmorvej, Copenhagen, Denmark: Netherlands Institute of Mental Health and Addiction. World Health Organizationspa
dc.relation.referencesMinisterio de Salud y Protección Social. Organización Internacional para las Migraciones. (2015). Manual de Cuidado a Cuidadores de Personas con Trastornos Mentales y/o Enfermedades Crónicas Discapacitantes.spa
dc.relation.referencesMinisterio del Trabajo. (22 de Julio de 2019). Resolución Número 2404 de 2019. Colombiaspa
dc.relation.referencesMinisterio de Trabajo. (2015, Diciembre). Protocolo de Acciones de Promoción, Prevención e Intervención de los Factores Psicosociales y sus Efectos en el Entorno Laboral. Bogotá D.C, Colombia: Fundación Cultural Javeriana de Artes Gráficas - JAVEGRAF.spa
dc.relation.referencesONU Migración, Ministerio de Salud y Protección Social. (s.f.). Clasificación Internacional del Funcionamiento, de la Discapacidad y de la Salud- CIF- Marco Conceptual de la Certificación y Registro de Discapacidad. Creative Commonsspa
dc.relation.referencesThe American Psychological Association . (2019). Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts American Psychological Association Guideline Development Panel for the Treatment of Depressive Disorders. NE, Washington D.C.: The American Psychological Association (APA)spa
dc.relation.referencesImprovement, I. f. (2016). Adult Depression in Primary Care. ICSI Health Care Guidelinespa
dc.relation.referencesKroenke K, S. R. (2001). he PHQ-9: validity of a brief depression severity measure. J Gen Intern Med , 16:606-13.spa
dc.relation.referencesO'Connor AM, B. C. (2007). Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis. Med Decis Making, 27:554-74.spa
dc.relation.referencesBrown, R. A. (1984). A psychoeducational approach to the treatment of depression: Comparison of group, individual, and minimal contact procedures. . Journal of Consulting and Clinical Psychology, 52(5), 774–783.spa
dc.relation.referencesRichards, D. A. (2008). Collaborative care for depression in UK primary care: a randomized comtrolled trial. Psychological Medicine, 38, 279–287.spa
dc.relation.referencesWilliams, J. M. (2008). Mindfulness-based cognitive therapy: further issues in current evidence and future research. Journal of Consulting and Clinical Psychology, 76, 524–529.spa
dc.relation.referencesChristensen, H. G. (2004). Delivering interventions for depression by using the internet: randomised controlled trial. British Medical Journal, 328, 265–268.spa
dc.relation.referencesSpek, V. (2007). Internet-based cognitive behaviour therapy for subthreshold depression in people over 50 years old. Ridderprint.spa
dc.relation.referencesMcCrone, P. C. (2003). Cost- utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy. European Journal of Neurology, 10, 687–694.spa
dc.relation.referencesKaltenthaler, E. P. (2008). Computerised cognitive- behavioural therapy for depression: systematic review. British Journal of Psychiatry, 193, 181–184spa
dc.relation.referencesDunn AL, M. H. (2005). Exercise treatment for depression: efficacy and dose response. Am J Prev Med, 28:1-8spa
dc.relation.referencesBabyak M, B. J. (2000). Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom Med, 62:633-38.spa
dc.relation.referencesSchuch FB, V.-M. M. (2011). Exercise and severe depression: prelimi- nary results of an add-on study. . J Affect Disord, 133:615-18.spa
dc.relation.referencesCooney GM, D. K. (2013). Exercise for depression. Cochrane Database of Systematic Reviews , CD004366.spa
dc.relation.referencesCuijpers P, S. M. (2014b). Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis. World Psychiatry, 13:56-67.spa
dc.relation.referencesChurchill R, M. T. (2013). 'Third wave' cognitive and behavioural therapies versus treatments as usual for depression. Cochrane Database Syst Rev, (10)CD008705.spa
dc.relation.referencesvan Hees ML, R. T. (2013). The effectiveness of individual interpersonal psycho- therapy as a treatment for major depressive disorder in adult outpatients: a systematic review. BMC Psychiatry , 13:22spa
dc.relation.referencesJakobsen JC, H. J. (2012a). Effects of cognitive therapy versus interpersonal psychotherapy in patients with major depressive disorder: a systematic review of randomized clinical trials with meta-analyses and trial sequential analyses. . Psychol Med , 42:1343-57.spa
dc.relation.referencesMcCarney RW, S. J. (2012). Effectiveness of mindfulness-based therapies in reducing symptoms of depression: a meta-analysis. Eur J Psychotherapy Couns, 14:279-99.spa
dc.relation.referencesPim Cuijpers, T. D. (2011b). Self-Guided Psychological Treatment for Depressive Symptoms: A Meta-Analysis. Plos One.spa
dc.relation.referencesJakobsen JC, H. J. (2011a). The effect of interpersonal psychotherapy and other psychodynamic therapies versus 'treatment as usual' in patients with major depressive disorder. PLoS One , 6:e19044.spa
dc.relation.referencesFlückiger C, D. R. (2014). Enduring effects of evidence-based psychotherapies in acute depression and anxiety disorders versus treatment as usual at follow-up: a longitudinal meta-analysis. Clin Psychol Rev, 34:367-75.spa
dc.relation.referencesOkumura Y, I. K. (2014). Efficacy and acceptability of group cognitive behavioral therapy for depression: a systematic review and meta-analysis. J Affect Disord , 164:155-64.spa
dc.relation.referencesJAN SCOTT, S. P. (2003). Use of cognitive therapy for relapse prevention in chronic depression in chronic depression Cost-effectiveness study . BRITI SH JOURNA L O F P SYCHIATRY, 182, 221-227.spa
dc.relation.referencesCharles F. Reynolds III, M., Ellen Frank, P., James M. Perel, P., & al, e. (1999). Nortriptyline and Interpersonal Psychotherapy as Maintenance Therapies for Recurrent Major Depression. JAMA, 281(1):39-45.spa
dc.relation.referencesH C Schulberg 1, M. R. (1996). Treating major depression in primary care practice. Eightmonth clinical outcomes. Arch Gen Psychiatry ., 53(10):913-9.spa
dc.relation.referencesFrank, E. &. (1990). Interpersonal psychotherapy for depression: Overview, clinical efficacy, and future directions. Clinical Psychology: Science and Practice, 2(4), 349– 369.spa
dc.relation.referencesMazzucchelli T, K. R. (2009). Behavioral activation treatments for depression in adults: a meta- analysis and review. Cin Psychol Sci Prac , 16:383-411spa
dc.relation.referencesPim Cuijpers, A. v. (2007). Behavioral activation treatments of depression: a meta-analysis. Clin Psychol Rev ., 27(3):318-26.spa
dc.relation.referencesSona Dimidjian, S. D. (2006). Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol ., 74(4):658-70.spa
dc.relation.referencesPim Cuijpers, G. A. (2011a). Psychological treatment of depression: results of a series of meta-analyses. Nord J Psychiatry, 65(6):354-64.spa
dc.relation.referencesSheffield, J. S. (2006). Evaluation of universal, indicated, and combined cognitivebehavioral approaches to the prevention of depression among adlescents. Journal of Consulting and Clinical Psychology., 74:66-79.spa
dc.relation.referencesPim Cuijpers, E. K. (2014a). Managing depression in older age: psychological interventions. Epub.spa
dc.relation.referencesGuy Bodenmann, B. P. (2008). Effects of coping-oriented couples therapy on depression: a randomized clinical trial. J Consult Clin Psychol ., 76(6):944-54.spa
dc.relation.referencesN Bedi, C. C. (2000). Assessing effectiveness of treatment of depression in primary care. Partially randomised preference trial. Br J Psychiatry ., 177:312-8.spa
dc.relation.referencesJeanne C Watson, L. B. (2003). Comparing the effectiveness of process-experiential with cognitive-behavioral psychotherapy in the treatment of depression. J Consult Clin Psychol . , 71(4):773-81spa
dc.relation.referencesRHONDA N. GOLDMAN, L. S. (2006). The effects of adding emotion-focused interventions to the therapeutic relationship in the treatment of depression. Psychotherapy Research , 16(5):537-549.spa
dc.relation.referencesGreenberg, L. S. (1998). Experiential therapy of depression: Differential effects of clientcentered relationship conditions and process experiential interventions. . Psychotherapy Research, 8(2), 210–224.spa
dc.relation.referencesFriedli, K. K. (2000). The economics of employing a counsellor in general practice: analysis of data from a randomised controlled trial. British Journal of General Practice, 50, 276–283.spa
dc.relation.referencesSimpson, S. C. (2003). A randomized controlled trial to evaluate the effectiveness and costeffectiveness of psychodynamic counselling for general practice patients with chronic depression. Psychological Medicine, 33, 229–239.spa
dc.relation.referencesVan, H. L. (2008). Predicting the outcome of antidepressants and psychotherapy for depression: a qualitative, systematic review. . Harvard Review of Psychiatry, 16, 225–234.spa
dc.relation.referencesJouko K Salminen, H. K.-H. (2008). Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study. Psychother Psychosom ., 77(6):351-7.spa
dc.relation.referencesMcLean, P. D. (1979). Clinical depression: Comparative efficacy of outpatient treatments. Journal of Consulting and Clinical Psychology, 47(5), 818–836.spa
dc.relation.referencesGiuseppe Maina, G. R. (2008). Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: long-term results. J Affect Disord ., 114(1-3):200-7spa
dc.relation.referencesKool, S. D. (2003). Changes in personality pathology after pharmacotherapy and combined therapy for depressed patients. Journal of Personality Disorders, 17(1), 60–72.spa
dc.relation.referencesAssociation, A. P. (2010). PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder. American Psychiatric Association.spa
dc.relation.referencesKaton W, R. P. (1996). A multifaceted intervention to improve treatment of depression in primary care. . Arch Gen Psychiatry, 53:924-32spa
dc.relation.referencesFournier JC, D. R. (2010). Antidepressant drug effects and depression severity: a patientlevel meta-analysis. . JAMA, 303:47-53.spa
dc.relation.referencesKeller MB, K. J. (1998). Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA, 280:1665-72.spa
dc.relation.referencesRMA., H. (2001). Clinical importance of long-term antidepressant treatment. Br J Psychiatry Suppl, 179:S4-S8.spa
dc.relation.referencesJF., G. (1993). Antidepressant maintenance medications: when to discontinue and how to stop. J Clin Psychiatry , 54:39-47.spa
dc.relation.referencesTrivedi MH, K. B. (2001). Algorithm for the treatment of chronic depression. J Clin Psychiatry , 62:22- 29.spa
dc.relation.referencesBarbey, J. T. (1998). SSRI safety in overdose. Journal of Clinical Psychiatry,, 59 (Suppl. 15), 42–48.spa
dc.relation.referencesGoeringer, K. E. (2000). Post mortem forensic toxicology of selective serotonin reuptake inhibitors: a review of pharmacology and report of 168 cases. . Journal of Forensic Sciences,, 45, 633–648.spa
dc.relation.referencesCohen, H. W. (2000). Excess risk of myocardial infarction in patients treated with antidepressant medication: association with use of tricyclic agents. American Journal of Medicine, 108, 2–8.spa
dc.relation.referencesMeier, C. R. (2001). Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction. British Journal of Clinical Pharmacology, 52, 179–184.spa
dc.relation.referencesSauer, W. H. (2001). elective serotonin reuptake inhibitors and myocardial infarction. Circulation, 104, 1894–1898spa
dc.relation.referencesMusselman, D. L. (1998). The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Archives of General Psychiatry, 55, 580–592.spa
dc.relation.referencesPollock, B. G.-T. (2000). Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. Journal of Clinical Psychopharmacology, 20, 137–140.spa
dc.relation.referencesRasmussen, S. L. (1999). Cardiac safety of citalopram: prospective trials and retrospective analyses. Journal of Clinical Psycho- pharmacology, , 19, 407–415.spa
dc.relation.referencesZivin K, P. P. (2013). Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg. Am J Psychiatry, 170:642-50spa
dc.relation.referencesZivin K, P. P. (2013). Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg. Am J Psychiatry, 170:642-50spa
dc.relation.referencesSteven P. Roosen, M., & and Kristen M. Suthers, M. (1998). Antidepressant Response in Late-life Depression. J Clinic Psychiatry, 59 (Suppl 10).spa
dc.relation.referencesStrik, J. J. (2000). Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebocontrolled trial. Psychosomatic Medicine, 62, 783–789.spa
dc.relation.referencesHewer, W. R. (1995). Cardiovascular effects of fluvoxamine and maprotiline antidepressant treatment: effects on cognitive function and psychomotor performance. International Clinical Psychopharmacology, 15, 305–318spa
dc.relation.referencesGarnier, R. A. (1993). Acute fluvoxamine poisoning. Journal of International Medical Research, 21, 197–208.spa
dc.relation.referencesGlassman, A. H. (2002). Sertraline treatment of major depression in patients with acute MI or unstable angina. Journal of the American Medical Association, 288, 701–709.spa
dc.relation.referencesCipriani, A. F. (2009). Comparative efficacy and acceptability of 12 new generation antidepressants: a multiple treatments meta- analysis. The Lancet, 373, 746–758.spa
dc.relation.referencesRoose, S. P. (1989). Cardiovascular effects of tricyclic antidepressants in depressed patients with and without heart disease. Journal of Clinical Psychiatry Monograph, 7, 1–19.spa
dc.relation.referencesGlassman, A. H. (1993). The safety of tricyclic antidepressants in cardiac patients. Risk– benefit reconsidered. Journal of the American Medical Association, 269, 2673– 2675.spa
dc.relation.referencesRoose, S. P. (1987). Tricyclic antidepressants in depressed patients with cardiac conduction disease. Archives of General Psychiatry, 44, 273–275.spa
dc.relation.referencesShah, R. U. (2001). Trends in deaths from drug overdose and poisoning in England and Wales 1993–1998. Journal of Public Health Medicine, 23, 242–246.spa
dc.relation.referencesA Wade, K. G. (2007). A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder. Curr Med Res Opin ., Jul;23(7):1605-14.spa
dc.relation.referencesSchatzberg, A. F. (2002). Pharmacological principles of antidepressant efficacy. Human Psychopharmacology.spa
dc.relation.referencesNutt, D. J. (2002). Tolerability and safety aspects of mirtazapine. . Human Psychopharmacology, 17 (Suppl. 1), S37–S41.spa
dc.relation.referencesVelazquez, C. C. (2001). Relative safety of mirtazapine overdose. Veterinary and Human Toxicology, 43, 342–344.spa
dc.relation.referencesFeighner, J. P. (1995). Cardiovascular safety in depressed patients: focus on venlafaxine. Journal of Clinical Psychiatry, 56, 574–579.spa
dc.relation.referencesWhyte, I. M. (2003). Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. QJM, 96, 369–374spa
dc.relation.referencesBuckley, N. A. (2002). Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of UK mortality data. British Medical Journal, 325, 1332–1333.spa
dc.relation.referencesMHRA. (2004). Report of the CSM Expert Working Group on the Safety of Selective Serotonin Reuptake Inhibitor Antidepressants. Obtenido de http://www.mhra. gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdfspa
dc.relation.referencesJanowsky, D. C. (1983). Trazodone-aggravated ventricular arrhythmias. Journal of Clinical Psychopharmacology, 3, 372–376.spa
dc.relation.referencesChong, S. A. (2001). Cardiac effects of psychotropic drugs. Annals, Academy of Medicine, Singapore, 30, 625–631.spa
dc.relation.referencesReilly, J. G. (2000). QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet,, 1048–1052.spa
dc.relation.referencesManeeton N, M. B. (2012). Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials. BMC Psychiatry, 12:160.spa
dc.relation.referencesMarcus RN, M. R. (2008). The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol , 28:156-65.spa
dc.relation.referencesBerman RM, M. R. (2007). The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebocontrolled study. . J Clin Psychiatry, 68:843-53.spa
dc.relation.referencesNierenberg, A. A. (1995). Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. American Journal of Psychiatry, 152, 1500–1503.spa
dc.relation.referencesNierenberg, A. A. (2000). Timing of onsent of antidepressant response with fluoxetine treatment. American Journal of Psychiatry, 157, 1423–1428.spa
dc.relation.referencesSzegedi, A. J. (2009). Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. Journal of Clinical Psychiatry,, 70, 344–353.spa
dc.relation.referencesStassen, H. H.-S. (1993). Time course of improvement under antidepressant treatment: a survival-analytical approach. European Neuropsychopharmacology, 3, 127–135.spa
dc.relation.referencesSzegedi, A. M. (2003). Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression. Journal of Clinical Psychiatry,, 64, 413–420.spa
dc.relation.referencesJakubovski E, V. A. (2016). Systematic review and meta-analysis: dose-response relationship of selective serotonin reuptake inhibitors in major depressive disorder. Am J Psychiatry, 173:174-83.spa
dc.relation.referencesFava M, R. J. (1994). Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study. Am J Psychiatry , 151:1372-74.spa
dc.relation.referencesPerry PJ, Z. C. (1994). Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response. J Clin Psychopharmacol , 14:230-40.spa
dc.relation.referencesNelson JC, M. C. (1991). A preliminary, open study of the combination of fluox- etine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry, 48:303- 07.spa
dc.relation.referencesTaylor, D. (1995). Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination. Interactions and therapeutic uses. British Journal of Psychiatry, 167, 575–580.spa
dc.relation.referencesMcGrath, P. J. (1993). A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression. . American Journal of Psychiatry, 150, 118–123.spa
dc.relation.referencesTrivedi, M. H. (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. American Journal of Psychiatry, 163, 28–40spa
dc.relation.referencesDam J, R. L. (1998). Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression. Pharmacopsychiatry, 31:48-54.spa
dc.relation.referencesMaes M, L. I. (1999). Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance. . J Clinic Psychopharmacol, 19:177-82spa
dc.relation.referencesCappiello A, M. C. (1995). Yohimbine augmentation of fluvoxamine in refractory depression: a single-blind study. . Biol Psychiatry, 38:765-67spa
dc.relation.referencesSchatzberg AF, R. A. (2005). Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. Arch Gen Psychiatry, 62:513-20spa
dc.relation.referencesThase ME, F. E. (2007). Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. Am J Psychiatry, 164:739- 52.spa
dc.relation.referencesBull SA, H. X. (2002). Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA , 288:1403-09spa
dc.relation.referencesThase ME, B. S. (1997). Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline. J Clin Psychiatry , 58:16-21spa
dc.relation.referencesBrown WA, H. W. (1995J ). Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another? J Clin Psychiatry, 56:30-34.spa
dc.relation.referencesAlan J Lenox-Smith, Q. J. (2008). Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor. Int Clin Psychopharmacol ., 23(3):113-9spa
dc.relation.referencesM F Poirier, P. B. (1999). Venlafaxine and paroxetine in treatment-resistant depression. Double-blind, randomised comparison. Br J Psychiatry ., 175:394spa
dc.relation.referencesBradley N Gaynes, A. J. (2008). The STAR*D study: Treating depression in the real world. Cleve Clin J Med ., 75(1):57-66spa
dc.relation.referencesRush, A. J. (2003). STAR*D treatment trial for depression. American Journal of Psychiatry, 160, 237spa
dc.relation.referencesPsychiatrists, R. C. (1997). Benzodiazepines: Risks, Benefits or Dependence. A Reevaluation. . Council Report CR59. London: Royal College of Psychiatrists.spa
dc.relation.referencesBritain, B. M. (2009). British National Formulary (BNF 57). . London: British Medical Association and the Royal Pharmaceutical Society of Great Britainspa
dc.relation.referencesDietrich, D. E. (1998). The use of anticonvulsants to augment antidepressant medication. Journal of Clinical Psychiatry, 59 (Suppl. 5), 51–58spa
dc.relation.referencesZhang, Z. J. (2008). The effectiveness of carbamazepine in unipolar depression: a double blind, randomised, placebo controlled study. Journal of Affective Disorders, 109, 91–97spa
dc.relation.referencesCullen, J. M. (1991). Carbamazepine for treatment- resistant melancholia. Journal of Clinical Psychiatry, 52, 472–476.spa
dc.relation.referencesKetter, T. A. (1995). Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression. Journal of Clinical Psychiatry, 56, 471–475spa
dc.relation.referencesDavis, L. L. (1996). Valproate as an antidepressant in major depressive disorder. Psychopharmacology Bulletin, 32, 647–652spa
dc.relation.referencesGeddes, J. R. (2009). Lamotrigine for treatment of bipolar depression: independent metaanalysis and meta-regression of individual patient data from five randomised trials. British Journal of Psychiatry, 194, 4–9spa
dc.relation.referencesHurley, S. C. (2002). Lamotrigine update and its use in mood disorders. Annals of Pharmacotherapy, 36, 860–873spa
dc.relation.referencesNormann, C. H. (2002). Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study. Journal of Clinical Psychiatry, 63, 337–344spa
dc.relation.referencesLoosen, P. T. (1987). The TRH stimulation test in psychiatric disorders: a review. Handbook of Clinical Psychoneuroendocrinology (eds P. T. Loosen & C. B. Nemeroff ), pp. 336– 360spa
dc.relation.referencesMaes, M. M. (1993). An evaluation of basal hypothalamic-pituitary-thyroid axis function in depression: results of a large- scaled and controlled study. Psychoneuroendocrinology, , 18, 607–620.spa
dc.relation.referencesAltshuler, L. L. (2001). Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. American Journal of Psychiatry,, 158, 1617–1622spa
dc.relation.referencesSteiner, M. R. (1978). Failure of L-triiodothyronine (T3) to potentiate tricyclic antidepressant response. Current Therapeutic Research, Clinical and Experimental, 23, 655–659spa
dc.relation.referencesGitlin, M. J. (1987). Failure of T3 to potentiate tricyclic antidepressant response. Journal of Affective Disorders, 13, 267–272.spa
dc.relation.referencesThase, M. E. (1989). Treatment of imipramine-resistant recurrent depression. I: An open clinical trial of adjunctive L-triiodothyronine. Journal of Clinical Psychiatry, 50, 385– 388.spa
dc.relation.referencesJoffe, R. T. (1990). A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants. Psychiatry Research, 32, 241–251.spa
dc.relation.referencesWisniewski, S. R. (2009). Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D Report. American Journal of Psychiatry, 166, 599–607spa
dc.relation.referencesSchwartz TL, A. N. (2004). An open-label study of adjunctive modafinil in patients with seda- tion related to serotonergic antidepressant therapy. J Clin Psychiatry, 65:1223-27.spa
dc.relation.referencesCandy M, J. L. (2008). Psychostimulants for depression (review). Cochrane Database of Systematic Reviews, CD006722.spa
dc.relation.referencesDunlop BW, C.-C. P. (2007). Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepi- ness: a double-blind, placebo-controlled study. J Clin Psychopharmacol, 27:614-19.spa
dc.relation.referencesFava M, T. M. (2005). A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. J Clin Psychiatry, 66:85-93spa
dc.relation.referencesWang F, L. E. (2014). The effects of tai chi on depression, anxiety, and psychological wellbeing: a systematic review and meta-analysis. Int J Behav Med , 21:605-17spa
dc.relation.referencesRavindran AV, L. R. (2009). Canadian network for mood and anxiety treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. complementary and alternative medicine treatments. J Affect Disord, 117:S54-64.spa
dc.relation.referencesL., L. (2014). The effectiveness of yoga for depression: a critical literature review. . Issues Ment Health Nurs, 35:265-76.spa
dc.relation.referencesSniezek DP, S. I. (2013). Acupuncture for treating anxiety and depression in women: a clinical systematic review. Med Acupunct, 25:164-72.spa
dc.relation.referencesMacPherson H, R. S. (2013). Acupuncture and counselling for depression in primary care: a randomised controlled trial. PLoS Med, 10:e1001518.spa
dc.relation.referencesFreeman MP, F. M. (2010). Complementary and alternative medicine in major depressive disorder: the American psychiatric association task force report. J Clin Psychiatry, 71:669-81.spa
dc.relation.referencesLeppämäki SJ, P. T. (2002). Randomized trial of the efficacy of bright-light exposure and aerobic exercise on depressive symptoms and serum lipids. J Clin Psychiatry, 63:316-21spa
dc.relation.referencesGolden RN, G. B. (2005). The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry, 162:656-62.spa
dc.relation.referencesJorm AF, C. H. (2002). Effectiveness of complementary and self-help treat- ments for depression. Med J Aust, 176:S84-S96.spa
dc.relation.referencesPrasko J, H. J. (2002). Bright light therapy and/or imipramine for inpatients with recurrent non-seasonal depression. Neuro Endocrinol Lett , 23:109-13spa
dc.relation.referencesBenedetti F, C. C. (2003). Morning light treatment hastens the antidepressant effect of citalopram: a placebo-controlled trial. J Clin Psychiatry, 64:648-53.spa
dc.relation.referencesAppleton KM, R. P. (2010). Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr, 91:757-70.spa
dc.relation.referencesSiwek M, D. D.-Z. (2010). Serum zinc level in depressed patients during zinc supplementation of imipramine treatment. J Affect Disord, 126:447-52.spa
dc.relation.referencesColangelo LA, H. K. (2009). Higher dietary intake of long-chair w-3 polyunsaturated fatty acids is inversely associated with depressive symptoms in women. Nutrition, 25:1011-19spa
dc.relation.referencesBloch MH, H. J. (2012). Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Mol Psychiatry, 17:1272-82.spa
dc.relation.referencesShaffer JA, E. D. (2014). Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials. . Psychosom Med , 76:190-96.spa
dc.relation.referencesLi G, M. L. (2014). Efficacy of vitamin D supplementation in depression in adults: a systematic review. J Clin Endocrinol Metab, 99:757-67.spa
dc.relation.referencesGeddes JR, C. S. (2003). Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet , 361:653-61spa
dc.relation.referencesKellner, C. H. (2007). Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the consortium for research in electroconvulsive therapy (CORE). Archives of General Psychiatry, 63, 1337–1344spa
dc.relation.referencesLorena Rami, M. B. (2004). Absence of additional cognitive impairment in schizophrenia patients during maintenance electroconvulsive therapy. Schizophr Bull , 30(1):185- 9spa
dc.relation.referencesWijkstra, J. &. (2005). Successful maintenance electroconvulsive therapy for more than seven years. . Journal of ECT, 21, 171–173.spa
dc.relation.referencesZisselman, M. H. (2007). Long-term weekly continuation electroconvulsive therapy: a case series. Journal of ECT, 23, 274–277.spa
dc.relation.referencesUK ECT Review Group, T. (2003). Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet, 361:799-808.spa
dc.relation.referencesAnderson EL, R. I. (2009). ECT in pregnancy: a review of the literature from 1941 to 2007. Psychosomatic Med , 71:235-42.spa
dc.relation.referencesHerrmann, L. L. (2006). actors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression. Journal of Clinical Psychiatry, 67, 1870–1876.spa
dc.relation.referencesRaymond W Lam, P. C.-H. (2008). Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis. Can J Psychiatry ., 53(9):621-31.spa
dc.relation.referencesHarden, C. L. (2000). A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy and Behavior, 1, 93–99.spa
dc.relation.referencesLinde K, B. M. (2008). St John's wort for major depression. Cochrane Database Syst Rev, CD000448.spa
dc.relation.referencesSmith CA, H. P. (2010). Acupuncture for depression. Cochrane Database Syst Rev, CD004046.spa
dc.relation.referencesHausenblas HA, S. D. (2013). Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. J Integr Med, 11:377-83.spa
dc.relation.referencesImprovement, I. f. (Noviembre de 2021). ICSI. Guidelines. Obtenido de https://www.icsi.org/guideline/depression/spa
dc.relation.referencesAssociation, A. P. (Noviembre de 2021). APA- Approved Standards and Guidelines. Obtenido de https://www.apa.org/about/policy/approved-guidelinesspa
dc.relation.referencesExcellence, N. I. (Noviembre de 2021). NICE guidelines. Obtenido de https://www.nice.org.uk/about/what-we-do/our-programmes/niceguidance/nice-guidelinesspa
dc.relation.referencesDavid Taylor, T. R. (2021). The Maudsley. Prescribing Guidelines in Psychiatry. 13th Edition. West Sussex, PO19 8SQ, UK: The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK.spa
dc.relation.referencesGilbody S, B. P. (2006). Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med, 166:2314-21.spa
dc.relation.referencesHunkeler EM, K. W. (2006). Long term outcomes from the IMPACT randomised trial for depressed elderly patients in primary care. BMJ, 332:259-63.spa
dc.relation.referencesSimon GE, K. W. (2001). Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. Am J Psychiatry, 158:1638-44.spa
dc.relation.referencesKaton W, V. K. (1999). Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychiatry, 56:1109-15.spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.licenseAtribución-NoComercial-SinDerivadas 4.0 Internacionalspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/spa
dc.subject.ddc610 - Medicina y salud::616 - Enfermedadesspa
dc.subject.otherDepresión
dc.subject.otherDepression
dc.subject.proposalDepresiónspa
dc.subject.proposalTrastorno depresivo recurrentespa
dc.subject.proposalEpisodio depresivospa
dc.subject.proposalProtocolospa
dc.subject.proposalLineamientosspa
dc.subject.proposalDepressioneng
dc.subject.proposalRecurrent depressive disordereng
dc.subject.proposalDepressive episodeeng
dc.subject.proposalProtocoleng
dc.subject.proposalRecommendationseng
dc.titleProtocolo basado en la evidencia para el diagnóstico y tratamiento del paciente adulto con depresión en el Hospital Universitario Nacional de Colombiaspa
dc.title.translatedEvidence-based protocol for the diagnosis and treatment of adult patients with depression at the Colombia National University Hospitaleng
dc.typeTrabajo de grado - Especialidad Médicaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_bdccspa
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/masterThesisspa
dc.type.redcolhttp://purl.org/redcol/resource_type/TMspa
dc.type.versioninfo:eu-repo/semantics/acceptedVersionspa
dcterms.audience.professionaldevelopmentInvestigadoresspa
dcterms.audience.professionaldevelopmentPadres y familiasspa
dcterms.audience.professionaldevelopmentPersonal de apoyo escolarspa
dcterms.audience.professionaldevelopmentPúblico generalspa
oaire.accessrightshttp://purl.org/coar/access_right/c_abf2spa

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
1020762424.2021 - Luisa Fernanda Morales Pinilla.pdf
Tamaño:
942.78 KB
Formato:
Adobe Portable Document Format
Descripción:
Tesis de especialidad medica en Psiquiatría

Bloque de licencias

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
license.txt
Tamaño:
3.98 KB
Formato:
Item-specific license agreed upon to submission
Descripción: